Active, Not Recruiting
Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma
NCT04674683
- Conditions
- Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +17 more
- Locations
-
- Comprehensive Blood and Cancer Center Bakersfield, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Innovative Clinical Research Institute (ICRI) Pasadena, California, United States
- Emad Ibrahim, MD, INC Redlands, California, United States